|
Volumn 7, Issue 10, 2001, Pages 2998-3005
|
A selective Cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express Cyclooxygenase-2
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENTARY DNA;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NS 938;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER RADIOTHERAPY;
COLON CARCINOMA;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
ENZYME INHIBITION;
EPITHELIUM CELL;
FLOW CYTOMETRY;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
LUNG CARCINOMA;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RADIOSENSITIVITY;
RADIOSENSITIZATION;
ANIMALS;
APOPTOSIS;
CELL SURVIVAL;
CELLS, CULTURED;
COMBINED MODALITY THERAPY;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DNA, ANTISENSE;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
EPITHELIAL CELLS;
HUMANS;
INTESTINAL MUCOSA;
ISOENZYMES;
MEMBRANE PROTEINS;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
NITROBENZENES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RATS;
SULFONAMIDES;
TIME FACTORS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0034799144
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (187)
|
References (48)
|